DocSym
β
Searchsearch
Search
(Y46.8) Antispasticity drugs
More details coming soon
24 262 in individuals diagnosis antispasticity drugs confirmed
2 651 deaths with diagnosis antispasticity drugs
11% mortality rate associated with the disease antispasticity drugs
Diagnosis antispasticity drugs is diagnosed Women are 27.64% more likely than Men
8 778
Men receive the diagnosis antispasticity drugs
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
15 484
Women receive the diagnosis antispasticity drugs
2 651 (17.1 %)Died from this diagnosis.
Risk Group for the Disease antispasticity drugs - Men aged 25-29 and Women aged 60-64
In Men diagnosis is most often set at age 0-5, 25-39, 50-59, 70-74
Less common in men the disease occurs at Age 0-1, 5-24, 40-49, 60-69, 75-95+Less common in women the disease occurs at Age 0-1, 5-34, 45-49, 85-95+
In Women diagnosis is most often set at age 0-5, 35-44, 50-84
Disease Features antispasticity drugs
Absence or low individual and public risk
Antispasticity drugs - what does this mean
Antispasticity drugs are medications used to reduce muscle spasticity in people with neurological conditions such as multiple sclerosis, cerebral palsy, and spinal cord injury. these drugs work by blocking the transmission of nerve signals from the brain to the affected muscles, thus reducing the severity of spasticity and improving the patient's range of motion and ability to move.
What happens during the disease - antispasticity drugs
Antispasticity drugs work by inhibiting the release of acetylcholine, a neurotransmitter that is responsible for muscle contraction. this reduces the amount of muscle spasms and rigidity, allowing for improved movement and flexibility. these drugs can also reduce pain associated with muscle spasms and rigidity, as well as improve overall motor control.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete physical examination
- Muscle strength testing
- Neurological examination
- X-rays
- MRI scan
- Blood tests
- Urine tests
- Electromyography (EMG)
- Nerve conduction studies
- Antispasticity drugs
Treatment and Medical Assistance
Main Goal of Treatment: Reduce spasticity in muscles
- Prescribe antispasticity drugs
- Provide physical therapy
- Recommend stretching exercises
- Instruct patient on proper posture and positioning
- Encourage patient to participate in regular physical activity
- Advise patient on proper nutrition and hydration
- Monitor patient’s progress and adjust treatment plan as needed
13 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Antispasticity drugs - Prevention
Antispasticity drugs are medications used to reduce muscle spasms and improve movement control in people with conditions such as multiple sclerosis, cerebral palsy, and spinal cord injury. to prevent the need for antispasticity drugs, it is important to maintain good physical health, including regular exercise and stretching, as well as good mental health, such as stress management and relaxation techniques. additionally, it is important to seek medical advice if any symptoms of muscle spasms or movement control issues are noticed.